CATALYST PHARMACEUTICALS, INC.: accounts_payable
| Value | {"amount": 3391000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-03-31) |
| Status | current |
| Entity | CATALYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5e6c96ef-85d8-45c1-a56e-ea64be59193e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-23-140701Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001369568/accounts-payable/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5e6c96ef-85d8-45c1-a56e-ea64be59193e
History
- no predecessors — first report